Article
Sacral stimulation: Improvements in QoL fade over the long term
Although quality of life improves significantly 6 months after treatmentwith sacral neuromodulation for voiding dysfunction, the reported qualityof life indicators are not statistically significant in the long term. However,not even the mitigation of symptoms is enough to keep patients happy overtime, said Anurag K. Das, MD, during a presentation at the AUA meeting Sunday.
Related Videos
Sarah Razavi, MD, discusses the physical toll of ureteroscopy on urologists
Clinical Outcomes of Ultra-Low PSA Responses in Patients With mHSPC Receiving Darolutamide Plus ADT
Treatment or Lack of Treatment of Small Renal Masses
The current treatment landscape of mHSPC
Strengths and Weaknesses of Imaging Modalities in ccRCC
BPH: Strategies for Guiding Patients From Medication to Intervention
Representation of Black men with mHSPC in clinical trials
Post Hoc Analysis of ARANOTE; Ultra-Low PSA Responses
Study results affirm effectiveness of evolving prostate cancer therapies
Non–Muscle Invasive-Bladder Cancer Overview
Related Content
